Taiwan FDA registration f6c54f6861b2a67b60354cbfd51954c0
“Imaxeon” MEDRAD Centargo Replacement Spike
TW: “益邁森” 注射系統輸液組套刺針
Taiwan·Risk Class 2·MD·IMAXEON PTY LTD.·Registered Mar 30, 2021 – Mar 30, 2026ExpiredRegistration details
- Analysis ID
- f6c54f6861b2a67b60354cbfd51954c0
- License Form
- Ministry of Health Medical Device Import No. 034481
- Customs Code
- DHA05603448107
Company information
- Manufacturer
- IMAXEON PTY LTD.
- Manufacturer Country
- Australia
- Authorized Representative
- HSIEN TAI INSTRUMENTS CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular devices
- Product Type (Level 2)
- E1650 Vascular photography syringes and syringes
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Mar 30, 2021
- Expiry Date
- Mar 30, 2026
About this record
Access comprehensive regulatory information for “Imaxeon” MEDRAD Centargo Replacement Spike in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f6c54f6861b2a67b60354cbfd51954c0 and manufactured by IMAXEON PTY LTD.. The authorized representative in Taiwan is HSIEN TAI INSTRUMENTS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices